Potential Benefits of GLP-1 Agonists Side Effects of GLP-1 Agonists Next Steps: Taking Action with GLP-1 Therapies Conclusion GLP-1, or Glucagon-like Peptide-1, is transforming the way we approach metabolic health
This process of longitudinal data collection, commonly referred to in sport as the biological passport, looks for variations of an individual athletes biomarkers to determine the likelihood of doping
These nutrient-based secretagogues include: Dietary lipids, especially triacylglycerol which is the primary fat found in foods Dietary carbohydrates, particularly those yielding glucose Short chain fatty acids (SCFAs) produced from fiber fermentation by gut microbes The high density of L-cells in the large intestine makes it a prime target for SCFA-mediated GLP-1 secretion
The trade-off is cost
Ghoshal, M
Here's what you need to know: Digestive side effects are the most common, including nausea (44%), diarrhea (30%), vomiting (24%), and constipation (24%)